Mental and Cognitive Health Library
Every article, presentation, spotlight, and news item we've tagged to Mental and Cognitive Health.
Showing 1–24 of 196
Early Cognitive Detection Transforms Dementia Prevention
Early detection of cognitive decline now enables intervention before irreversible neurodegeneration progresses, fundamentally altering the treatment trajectory for Alzheimer's disease. Multimodal approaches combining pharmacotherapy, lifestyle modification, and personalized risk assessment are shifting dementia care from late-stage management to proactive disease prevention.
[Articles] Risk factors for early-onset and late-onset dementia: a prospective cohort study
Modifiable risk factors drive both early-onset and late-onset dementia, with distinct profiles emerging between the two presentations. Identifying these factors creates measurable intervention points for primary prevention before cognitive decline becomes apparent.
Why Dementia Prevention Knowledge Fails Into Action
Nearly half of dementia cases stem from modifiable risk factors, yet population-level prevention programs show inconsistent results. Mass media campaigns reach large audiences but produce only marginal improvements in knowledge or behavior—suggesting that scale of reach does not guarantee meaningful cognitive protection.
Systemic Aging Drives Cognitive Decline: Beyond Brain-Only Models
Cognitive function declines with age not as an isolated neurological process but through systemic physiological changes affecting brain metabolism, circulation, and cellular maintenance. Understanding these interconnections reveals that cognitive aging is addressable through interventions targeting the body's core functions rather than the brain alone.
Long‐Term Stress Adaptation as a Highly‐Conserved Key Factor in Yeast Aging
Prolonged stress—distinct from acute stress—activates molecular pathways in yeast that recapitulate aging hallmarks including proteostasis collapse and epigenetic dysregulation. These changes are reversible upon stress relief, and the underlying genes are conserved across all life domains, suggesting aging may represent a maladaptive long-term stress response rather than passive damage accumulation.
The brain doesn’t have to decline
Cognitive decline is increasingly recognized as preventable and reversible through targeted cognitive training and integrated lifestyle interventions, rather than an inevitable consequence of aging. A landmark 20-year study found that speed-processing training reduced dementia incidence by 25%, while clinical cases demonstrate substantial cognitive recovery when multiple physiological and psychological factors are addressed simultaneously.
Preventive Framework Targets Modifiable Risk in Aging
A conceptual framework for preventive health in older adults identifies modifiable risk factors and intervention points across multiple life domains to reduce chronic disease burden and preserve functional capacity. This approach shifts focus from disease management to proactive risk reduction during the aging process.
Multifaceted Declines in Everyday Decision-Making in Older Adults: A Think-Aloud Study
Older adults exhibit measurable declines in everyday decision-making driven by sensory and cognitive changes, with environmental design and support structures demonstrating capacity to mitigate these effects. This directly impacts functional independence and quality of life across the lifespan.
Synaptic Protection Slows Alzheimer's Network Decline
LM11A-31, an investigational oral compound, preserves functional connectivity between brain regions in early-stage Alzheimer's disease by protecting synaptic connections rather than clearing amyloid plaques. This shifts the therapeutic target from protein removal to network resilience, suggesting that maintaining neuronal communication may be as critical as addressing pathological hallmarks for slowing cognitive decline.
Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization
Mendelian randomization analysis of drug targets reveals limited repurposing opportunities for vascular dementia prevention. Beta-blockers targeting ADRB1 showed potential benefit, while ACE inhibitors demonstrated a possible risk signal, suggesting current cardiovascular drug strategies may not directly translate to dementia prevention.
Lifetime Cognitive Enrichment Associated With Less Dementia
Lifetime cognitive enrichment from childhood through late life is associated with a 38% reduced dementia risk and delays cognitive decline by 5–7 years. The protective effect accumulates across all life stages, with late-life engagement showing the strongest individual contribution to risk reduction.
[Articles] Repeated measures of physical activity before dementia diagnosis in community-dwelling older adults: a longitudinal study
Repeated measures of physical activity in community-dwelling older adults reveal that the protective association with dementia risk varies depending on timing relative to diagnosis, suggesting that activity patterns in the years immediately preceding cognitive decline may be more predictive than earlier lifetime activity. This finding reframes physical activity from a static risk factor into a dynamic variable whose relevance to dementia prevention depends on proximity to disease onset.
Associations of Instrumental Activities of Daily Living, Self-Reported Falls, and Depression With Subjective Cognitive Decline Among Older Adults
Subjective cognitive decline in older adults correlates with reduced capacity for instrumental daily activities, prior falls, and depressive symptoms. This association suggests that perceived cognitive changes may reflect broader functional and neurological stress rather than isolated memory loss.
#390 ‒ AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration
This AMA addresses multiple dimensions of disease prevention and optimization: family history assessment as a risk stratification tool, cardiovascular disease prevention through metabolic and behavioral intervention, strength training efficiency for maintaining muscle mass and metabolic function, dementia risk reduction through modifiable factors, NAD supplementation's role in cellular energy production, and hydration's foundational importance to physiological function. The aggregate effect of these interventions addresses primary prevention across multiple chronic disease pathways relevant to longevity.
Neuroscience of Vitality and Aging Conference in Boston
The Neuroscience of Vitality and Aging Conference brings together researchers, clinicians, policymakers, and investors to address brain health preservation and neurodegenerative disease prevention. The event recognizes brain aging as a modifiable biological process and aims to translate fragmented research across academia, industry, and policy into coordinated clinical advancement.
Regulatory Networks Drive Alzheimer's Cognitive Decline
Researchers used network analysis to identify regulatory drivers of cognitive decline in Alzheimer's disease, revealing that disease progression involves coordinated dysregulation across multiple biological pathways rather than isolated molecular defects. This systems-level understanding offers a foundation for identifying intervention points that address root mechanisms rather than single downstream symptoms.
Burnout Among Direct Care Workers in Chinese Long-term Care Facilities: A Multilevel Analysis Integrating the Stress Process and Job Demands–Resources Models
Burnout among direct care workers in Chinese long-term care facilities correlates with job demands, resource availability, and individual stress responses. Understanding these multilevel factors is critical for sustaining the quality of care delivered to aging populations and protecting workforce stability in geriatric settings.
Alzheon pushes oral Alzheimer’s pipeline forward
Alzheon has dosed the first healthy volunteers in a Phase 1 trial of ALZ-507, an oral Alzheimer's candidate designed to prevent amyloid clumping and correct APOE4 dysfunction. The drug represents a shift toward earlier intervention and simplified delivery in a disease where accessibility and tolerability have historically limited treatment adoption.
Midlife Mobility Decline Signals Systemic Aging Process
Mobility decline begins in midlife and represents a multifactorial process involving physical, neuromuscular, and cognitive changes. Preserving movement capacity directly supports functional independence, social engagement, and access to activities that sustain quality of life in older age.
Protect the eyes, protect the brain—a potentially simple lever for dementia risk
Uncorrected cataracts appear associated with elevated dementia risk, and cataract surgery may reduce that risk. This relationship suggests that preserving visual input and the neural processing it supports plays a measurable role in cognitive preservation.
Trajectory of Cognitive Decline After Incident Hearing Loss: A 24-year Population-Based Longitudinal Cohort Study
Incident hearing loss accelerates cognitive decline over a 24-year period, with the trajectory of cognitive loss steeper in individuals who develop hearing loss compared to those with stable hearing. The magnitude of cognitive decline attributable to hearing loss appears substantial enough to warrant clinical attention in aging populations.
Can AI outsmart Alzheimer’s? $6.2m grant fund says yes
A $6.2 million NIH grant funds AI-driven analysis of 1,800 Alzheimer's-linked genes to identify genetic targets upstream of amyloid pathology, shifting focus from symptomatic treatment to early-stage vulnerability. Current amyloid-targeting drugs slow progression at best; identifying genetic determinants of susceptibility may enable earlier, more precise intervention before neurodegeneration becomes symptomatic.
Alzheimer's shifts from single drugs to multimodal brain optimization
Alzheimer's treatment is transitioning from single-target drug development toward multimodal approaches combining pharmacotherapy, neurotech, and regenerative medicine. AAIC 2026 reflects this shift, with emerging companies demonstrating that disease management now requires addressing multiple biological drivers simultaneously rather than pursuing one breakthrough intervention.
Alzheimer's Therapies Shift Detection From Clinic to Home
Effective disease-modifying therapies for Alzheimer's disease are forcing a diagnostic infrastructure shift from academic research to scalable clinical detection. Early identification now determines treatment efficacy, requiring systems that can identify pathology years before cognitive symptoms emerge.